Kailera Therapeutics, Inc. · NASDAQ:KLRA
Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported a 8.90% stake in Kailera Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 5, 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported a 8.90% stake in Kailera Therapeutics, Inc., 11,511,853 shares, as a passive investor on Jun 30, 2026. Filed Aug 5, 2026 (Schedule 13G).
- Stake
- 8.90%
- Shares
- 11,511,853
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 8.90% | 11,511,853 |
Source
Related
- Kailera Therapeutics, Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Kailera Therapeutics, Inc. shareholders
- Schedule 13G · Canada Pension Plan Investment Board · Aug 14, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026
- Form 4 · Renaud Ronald C JR · Jun 11, 2026
- Schedule 13D · BCPE Perseus Investor, LP · Apr 23, 2026
- Schedule 13D · BCLS Fund IV Investments, L.P. · Apr 23, 2026